| Kimberly Hujarski, CNP | |
|
1 Akron General Ave, Akron, OH 44307-2432 | |
| (330) 334-6000 | |
| Not Available |
| Full Name | Kimberly Hujarski |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 1 Akron General Ave, Akron, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134650666 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 020289 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Akron General Medical Center | Akron, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Akron General Medical Center | 8426961061 | 92 |
News Archive
Thousands of New Yorkers every year will suffer some form of facial paralysis, a diagnosis with many causes which can greatly affect a person's appearance and day-to-day functioning.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has won two significant patent re-examination cases brought by Isis Pharmaceuticals.
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
The WHO said Thursday that "it plans to recommend tighter nutritional standards in food aid for young children, a move activists say is necessary to improve donations from countries such as the United States," the Associated Press/Washington Post reports.
› Verified 9 days ago
| Entity Name | Akron General Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821035940 PECOS PAC ID: 8426961061 Enrollment ID: O20040206000686 |
News Archive
Thousands of New Yorkers every year will suffer some form of facial paralysis, a diagnosis with many causes which can greatly affect a person's appearance and day-to-day functioning.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has won two significant patent re-examination cases brought by Isis Pharmaceuticals.
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
The WHO said Thursday that "it plans to recommend tighter nutritional standards in food aid for young children, a move activists say is necessary to improve donations from countries such as the United States," the Associated Press/Washington Post reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Hujarski, CNP 1 Akron General Ave, Akron, OH 44307-2432 Ph: () - | Kimberly Hujarski, CNP 1 Akron General Ave, Akron, OH 44307-2432 Ph: (330) 334-6000 |
News Archive
Thousands of New Yorkers every year will suffer some form of facial paralysis, a diagnosis with many causes which can greatly affect a person's appearance and day-to-day functioning.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has won two significant patent re-examination cases brought by Isis Pharmaceuticals.
Eckert & Ziegler Strahlen- und Medizintechnik AG, a firm specializing in radioactive compounds for the treatment of cancer, has renewed the approval of its drug YTTRIGA (Yttrium-90 chloride) by the European Commission. Five years ago the European Medicines Agency EMA approved this drug for the first time and as a result of the current renewal process the drug has now been granted an indefinite approval.
The WHO said Thursday that "it plans to recommend tighter nutritional standards in food aid for young children, a move activists say is necessary to improve donations from countries such as the United States," the Associated Press/Washington Post reports.
› Verified 9 days ago
Shakeilah Carelle Burns, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 S Arlington St Unit 146, Akron, OH 44306 Phone: 330-355-7055 | |
Felicia Zabala, APRN. CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-5995 | |
Mrs. Molly A. Hockin, MSN, APRN, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 340 S Broadway St, Akron, OH 44308 Phone: 330-253-3100 | |
Sarah Elizabeth Bailey, CNP-APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 444 W Exchange St, Akron, OH 44302 Phone: 330-535-2671 | |
Heather Larson, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-6060 Fax: 330-543-6069 | |
Mrs. Erika Lynn Gross, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 224 W Exchange St, Suite 160, Akron, OH 44302 Phone: 330-344-6505 | |
Lisa Young, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 |